There’s a new filler in town (actually, two new fillers) and they’re billed as the next big thing in the fight against laugh lines. Galderma, the pharmaceutical company behind injectables like Restylane, Sculptra, and Dysport, has just announced FDA approval of two new fillers: Restylane Refyne and Defyne. The first was approved to treat moderate wrinkles and folds from the nose to mouth, while the latter is meant to plump and fill deep-set lines. Both are expected to be in doctors’ offices around the country by early next year.
While there are other fillers on the market that can plump wrinkles, Refyne and Defyne are meant to give a more natural-looking result than previously thought possible. Galderma claims results can last up to 12 months, which means you’ll likely need to get pricked twice a year to keep things looking smooth. But it’s the new type of hyaluronic acid in the filler gel that’s the real news here. The new technology is called XpresHAn—which is pronounced like a French person trying to say the word expression—and it allows the hyaluronic acid gel to flex within the skin as you move your face. So whether you’re smiling, frowning, or wrinkling your face any which way, the result looks soft and natural, not puffy or stiff.